LATEST UPDATES & INDUSTRY NEWS

Behind the scenes at Proxima Clinical Research

Proxima CRO Blog

January 2020 Newsletter: Promises, Promises.

Promises, Promises. Lot’s of pressure on NYE. Our resolution is to do more of what we’ve been doing. Giving the best service possible to small and emerging drug, medical device and diagnostic companies. So “our” promise is to keep on, keeping on.

Steps You Can Take to Answer If Your Product is A Drug or Medical Device

Drug versus device determination isn't always simple...make sure you get yours right.

Meet the Innovator: Edward Allegra from BioLum Sciences

This week, we spoke with Edward Allegra, CEO of BioLum Sciences, a current resident of Johnson & Johnson Innovation’s, JLABS@TMC (Texas Medical Center) in Houston, TX and the developer of the BioSense AMD (pending FDA clearance).

How to Choose a CRO: Top 5 Considerations When Choosing a CRO

There are a few top things you should consider when choosing your CRO Partner.

Innovation Tour & Networking Tour with Enventure

Join us for a tour of Proxima, a clinical research organization (CRO) located in the heart of Texas Medical Center Innovation.

BusinessWire: Proxima Clinical Research launches new campaign entitled "We Love Startups" along with an expert HelpDesk

Today, on Valentine’s Day, Proxima Clinical Research, Inc., a leading provider of clinical and regulatory solutions, launched a year-long campaign focused on emerging biotech and medical device companies known as “We Love Startups.”

Proxima teaching session at TMCx7: Navigating Clinical Trials for Medical Device Startups

Learn about clinical trial models, organizing and running your clinical trial, participant recruitment and retention strategies, designing your protocol and finding the right PI.

Proxima Clinical Research, Inc. Participates in FDA Sponsored Pediatric Medical Device Consortium

The Southwest National Pediatric Device Consortium (SWPDC), anchored by Texas Children’s Hospital and Baylor College of Medicine, recently received a prestigious P50 grant from the U.S. Food & Drug Administration (FDA).

Xconomy: Proxima Aims to Fill CRO Gap for Houston’s Growing Biotech Community

Medical research is big business in Houston, but life science companies sometimes find they’re missing out on the clinical trial services typically provided by contract research organizations (CROs).

Proxima Launch Party

Come celebrate with us at our launch party! It's happening at TMCx on April 23, 2018.